Zai Lab Limited - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ZLAB Nasdaq 2836 www.zailaboratory.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zai Lab Limited

Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Up for Week - May 29th, 2026 8:40 am
Zai Lab Announces Changes to Senior Leadership Team - May 21st, 2026 4:09 pm
Asian Equities Traded in the US as American Depositary Receipts Lower in Monday Trading - May 18th, 2026 8:44 am
Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading - May 15th, 2026 8:38 am
Asian Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading - May 11th, 2026 8:37 am
Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - May 11th, 2026 7:58 am
Zai Lab Receives U.S. FDA Fast Track Designation for Zocilurtatug Pelitecan (Zoci), a DLL3-Targeting ADC, for Treatment of Extrapulmonary Neuroendocrine Carcinomas (epNECs) - May 11th, 2026 5:00 am
Zai Lab Q1 Earnings Call Highlights - May 9th, 2026 3:05 am
Asian Equities Traded in the US as American Depositary Receipts Edge Higher Friday - May 8th, 2026 8:45 am
Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - May 7th, 2026 7:30 am
Zai Lab Announces First Quarter 2026 Financial Results and Recent Corporate Updates - May 7th, 2026 4:00 am
Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - Apr 30th, 2026 8:42 am
Asian Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading - Apr 29th, 2026 8:37 am
Assessing Zai Lab (ZLAB) Valuation After Recent Share Price Momentum And Analyst Target Reset - Apr 28th, 2026 5:06 am
Zai Lab Showcases 54% Brain Metastases Response for ZL-1310 ADC in SCLC at AACR Investor Call - Apr 26th, 2026 12:02 am
Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading - Apr 23rd, 2026 8:44 am
Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026 - Apr 22nd, 2026 5:30 am
Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy - Apr 19th, 2026 9:43 am
Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases - Apr 18th, 2026 7:00 am
Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer with Brain Metastases and Promising Activity in Other Neuroendocrine Carcinomas - Apr 17th, 2026 1:01 pm